Acadia Pharmaceuticals Inc. · NASDAQ:ACAD
Acadia Pharmaceuticals Inc. shareholders
As of Jun 30, 2026, 342 institutions reported holding Acadia Pharmaceuticals Inc., 97.9% of its shares. Largest: Baker Bros. Advisors LP, BlackRock and Vanguard. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Acadia Pharmaceuticals Inc. | Change | Filed |
|---|---|---|---|---|
| Baker Bros. Advisors LP | 42.9M | 24.9% | +16,214 | Aug 14, 2026 |
| BlackRock | 22.5M | 13.1% | +964K | Aug 7, 2026 |
| Vanguard | 15.7M | 9.1% | +315K | Aug 13, 2026 |
| State Street | 9.08M | 5.3% | +743K | Aug 7, 2026 |
| Rtw Investments, LP | 7.14M | 4.1% | no change | Aug 14, 2026 |
| Dimensional | 3.69M | 2.1% | +540K | Aug 11, 2026 |
| Geode Capital | 3.36M | 1.9% | −107K | Aug 12, 2026 |
| Palo Alto Investors LP | 2.86M | 1.7% | −8,599 | Aug 19, 2026 |
| Goldman Sachs | 2.58M | 1.5% | +1.02M | Aug 14, 2026 |
| Qube Research & Technologies Ltd | 2.45M | 1.4% | +1.5M | Aug 14, 2026 |